Skip to search formSkip to main contentSkip to account menu

60 ACTUAT tiotropium 0.00125 MG/ACTUAT Metered Dose Inhaler

Known as: TIOTROPIUM 1.25MCG/ACTUAT INHL,ORAL,60D,4GM, TIOTROPIUM 1.25MCG/ACTUAT 60D ORAL INHL, tiotropium bromide 1.25 MCG/ACTUAT Metered Dose Inhaler, 60 ACTUATS 
National Institutes of Health

Related topics

Related topics

5 relations
AsthmaBronchodilation [PE]Metered Dose Inhalertiotropium

Broader (1)

BRONCHODILATORS,ANTICHOLINERGIC

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
BACKGROUND Despite current guidelines, many patients with asthma remain symptomatic, particularly those intolerant of… 
Review
2017
Review
2017
A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
BACKGROUND Despite current guidelines, many patients with asthma remain symptomatic, particularly those intolerant of… 
Review
2017
Review
2017
[Efficacy and safety of tiotropium Respimat in the treatment of chronic obstructive pulmonary disease: systematic review].
Objective: To evaluate the efficacy and safety of tiotropium Respimat in the treatment of chronic obstructive pulmonary disease… 
2016
2016
Überlegenheit von Glycopyrronium im Vergleich zu Tiotropium in der früh-einsetzenden Bronchodilatation von Patienten mit moderater bis schwerer COPD – Die FAST Studie
2015
2015
P149 Once-daily tiotropium Respimat® add-on to at least ICS in adult patients with symptomatic asthma: pooled safety analysis
Background A high proportion of patients with asthma are symptomatic despite at least ICS maintenance therapy. Five trials aimed… 
Review
2014
Review
2014
Tiotropium HandiHaler improves the survival of patients with COPD: a systematic review and meta-analysis.
BACKGROUND Tiotropium HandiHaler (TioH) has been shown to improve lung function, exacerbations, and quality of life when added to… 
2014
2014
Anticholinergika und COPD – Tiotropium auch in geringer Dosierung sicher
2013
2013
Tiotropium verbessert Lungenfunktion bei Patienten mit schlecht kontrolliertem Asthma trotz Standard-Kombinationstherapie
2011
2011
The Efficacy And Safety Of Tiotropium Handihaler, 18 18 µg, Once Daily Plus PRN Salbutamol Versus Placebo Plus PRN Salbutamol In COPD Subjects Nave To Maintenance Therapy
2004
2004
Verringerung der Atemnot unter Alltagsbelastung bei COPD-Patienten und Beurteilung der Therapie nach 4-wöchiger Behandlung mit Tiotropium
Einleitung: Mit der Einfuhrung des langwirksamen inhalativen Anticholinergikums Tiotropium zur COPD-Therapie in Deutschland wurde… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)